Stock Traders Purchase High Volume of Clorox Put Options (NYSE:CLX)

Posted by Geri Gentry on Jul 30th, 2026

The Clorox Company (NYSE:CLX – Get Free Report) was the target of unusually large options trading activity on Tuesday. Traders purchased 15,112 put options on the stock. This is an increase of 153% compared to the average daily volume of 5,962 put options.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in CLX. Caitlin John LLC boosted its holdings in Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares in the last quarter. Darwin Wealth Management LLC bought a new position in shares of Clorox during the 2nd quarter worth approximately $29,000. Vision Financial Markets LLC boosted its stake in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after buying an additional 200 shares in the last quarter. Root Financial Partners LLC grew its position in Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares during the period. Finally, SHP Wealth Management acquired a new position in Clorox during the fourth quarter worth $35,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on CLX shares. Evercore restated an “underperform” rating and set a $98.00 target price on shares of Clorox in a research note on Thursday, July 23rd. Jefferies Financial Group lowered Clorox from a “buy” rating to a “hold” rating and cut their price target for the stock from $125.00 to $98.00 in a report on Tuesday. JPMorgan Chase & Co. reduced their price objective on Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a research report on Thursday, July 16th. Royal Bank Of Canada lowered their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Finally, Morgan Stanley cut their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $101.00.

View Our Latest Stock Report on Clorox

Clorox Stock Performance

CLX traded down $2.66 during trading on Thursday, reaching $96.97. 937,598 shares of the company’s stock were exchanged, compared to its average volume of 2,517,773. Clorox has a fifty-two week low of $84.70 and a fifty-two week high of $128.90. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The business has a 50 day moving average price of $95.46 and a 200 day moving average price of $103.79. The company has a market capitalization of $11.73 billion, a P/E ratio of 15.74 and a beta of 0.54.

Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.45 EPS. As a group, analysts predict that Clorox will post 5.52 earnings per share for the current fiscal year.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.